|Bid||35.17 x 0|
|Ask||35.19 x 0|
|Day's Range||34.91 - 35.31|
|52 Week Range||27.99 - 41.50|
|Beta (5Y Monthly)||0.79|
|PE Ratio (TTM)||11.09|
|Forward Dividend & Yield||1.96 (5.61%)|
|Ex-Dividend Date||Dec 01, 2022|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for GWO.TO
Great-West Lifeco will release its fourth quarter 2022 financial results after markets close on Wednesday, February 8, 2023.
Great-West Lifeco Inc. (the "Corporation") announced today that it has received approval from the Toronto Stock Exchange ("TSX") for the renewal of its Normal Course Issuer Bid ("NCIB").
Great-West Lifeco Inc. ("Lifeco") has been notified of an unsolicited mini-tender offer by Obatan LLC, made to residents of Ireland, to purchase up to 50,000 common shares of Lifeco. The unsolicited offer represents a discount of approximately 31.1% to the closing price of the common shares on the TSX on December 29, 2022, the last trading day before the offer was commenced. The common shares do not trade on a recognized stock exchange in Ireland.